Other
Available for sale investments
Amgen Available for sale investments increased by 34.7% to $11.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.3%, from $8.30B to $11.48B. Over 5 years (FY 2020 to FY 2025), Available for sale investments shows a downward trend with a -2.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase suggests higher liquidity and potential for capital gains, while a decrease may indicate asset liquidation or market value depreciation.
Detailed definition
This represents the fair value of debt securities that are not classified as held-to-maturity or trading. These assets a...
Peer comparison
Standard across insurance and banking sectors as part of the investment portfolio.
Metric ID:
other_available_for_sale_securities_debt_securitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.16B | $12.28B | $7.30B | $5.85B | $6.41B | $10.92B | $4.34B | $31.07B | $33.62B | $34.21B | $10.40B | $9.24B | $8.81B | $8.58B | $11.49B | $8.30B | $7.49B | $8.71B | $8.53B | $11.48B |
| QoQ Change | — | +71.5% | -40.5% | -19.9% | +9.6% | +70.3% | -60.3% | +616.6% | +8.2% | +1.8% | -69.6% | -11.2% | -4.6% | -2.7% | +33.9% | -27.7% | -9.8% | +16.3% | -2.1% | +34.7% |
| YoY Change | — | — | — | — | -10.4% | -11.0% | -40.6% | +430.8% | +424.2% | +213.2% | +140.0% | -70.3% | -73.8% | -74.9% | +10.4% | -10.1% | -15.0% | +1.5% | -25.8% | +38.3% |
Range$4.34B – $34.21B
CAGR+10.5%
Avg YoY Growth+57.9%
Median YoY Growth-10.3%
Available for sale investments at Other Companies
Frequently Asked Questions
- What is Amgen's available for sale investments?
- Amgen (AMGN) reported available for sale investments of $11.48B in Q1 2026.
- How has Amgen's available for sale investments changed year-over-year?
- Amgen's available for sale investments increased by 38.3% year-over-year, from $8.30B to $11.48B.
- What is the long-term trend for Amgen's available for sale investments?
- Over 5 years (2020 to 2025), Amgen's available for sale investments has grown at a -2.8% compound annual growth rate (CAGR), from $9.85B to $8.53B.
- What does available for sale investments mean?
- The fair market value of debt securities held for investment purposes that can be sold if needed.